MedTrace Logo

The Roles of Tissue Factor in Malignant Gliomas

NCT00201903 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2017-04-06

No results posted yet for this study

Summary

To explore the relationship between tissue factor levels, tumour progression, activation of blood coagulation and venous thromboembolism with malignant glioma

Conditions

Sponsors & Collaborators

  • Ontario Cancer Research Network

    collaborator NETWORK

  • Ontario Clinical Oncology Group (OCOG)

    lead OTHER

Principal Investigators

  • Agnes Lee, MD · Hamilton Health Sciences and McMaster University

  • William Geerts, MD · Sunnybrook Health Sciences Centre

  • Mark Levine, MD · Ontario Clinical Oncology Group (OCOG)

  • James Perry, MD · Toronto Sunnybrook Regional Cancer Centre

  • Janusz Rak · Hamilton Health Sciences and McMaster University

  • Jeffrey Weitz, MD · Hamilton Health Sciences and McMaster University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Completion
2006-10-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00201903 on ClinicalTrials.gov